BTTX
Better Therapeutics, Inc. Common Stock
BTTX
BTTX
Delisted
BTTX was delisted on the 15th of March, 2024.
14 hedge funds and large institutions have $2.77M invested in Better Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
61% less capital invested
Capital invested by funds: $7.16M → $2.77M (-$4.39M)
Holders
14
Holding in Top 10
–
Calls
$420K
Puts
$25K
Top Buyers
| 1 | +$147K | |
| 2 | +$118K | |
| 3 | +$107K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$76.6K |
| 5 |
State Street
Boston,
Massachusetts
|
+$71K |
Top Sellers
| 1 | -$1.74M | |
| 2 | -$1.18M | |
| 3 | -$540K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$340K |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$230K |